Decades Later, Congress Continues Debating the Preserve Access to Affordable Generics (and Biosimilars) Act; But will the Recent Jarkesy SCOTUS Decision Finally Put an End to the Insanity? By Kurt R. Karst & Michael D. Shumsky —

https://www.thefdalawblog.com/2024/08/decades-later-congress-continues-debating-the-preserve-access-to-affordable-generics-and-biosimilars-act-but-will-the-recent-jarkesy-scotus-decision-finally-put-an-end-to-the-insanity/?utm_source=rss&utm_medium=rss&utm_campaign=decades-later-congress-continues-debating-the-preserve-access-to-affordable-generics-and-biosimilars-act-but-will-the-recent-jarkesy-scotus-decision-finally-put-an-end-to-the-insanity